Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

The rapid adoption of the Omnipod 5 answered a question automated insulin delivery system manufacturers posed for years: with ...

PTC Inc. (NASDAQ:PTC) is one of the 12 best-augmented reality stocks to buy, according to analysts. On June 12, the company ...

Vuzix Corporation (NASDAQ:VUZI) is one of the 12 best-augmented reality stocks to buy, according to analysts. On June 24, ...

In multiple sclerosis (MS), an alteration of neuronal metabolism caused by dysfunction of its proteasome, the cellular machinery responsible for recycling proteins, contributes to neurodegeneration in ...